Treatment of hepatitis C in children: a systematic review (Q21136318)

title

Treatment of hepatitis C in children: a systematic review (English)

0 references

1 reference

1 July 2020

1 reference

4

Lisa Tjosvold

Lisa

Tjosvold

1 reference

17 August 2022

2

Karen Doucette

Karen

Doucette

1 reference

17 August 2022

3

Lisa Hartling

Lisa

Hartling

1 reference

17 August 2022

Jia Hu

1

Jia

Hu

1 reference

17 August 2022

Joan Robinson

series ordinal

5

author given names

Joan

author last names

Robinson

1 reference

Creative Commons Attribution 4.0 International

17 August 2022

language of work or name

English

0 references

publication date

13 July 2010

4 references

23 March 2019

21 March 2019

1 July 2020

25 October 2022

4 references

23 March 2019

21 March 2019

1 July 2020

25 October 2022

5

0 references

issue

7

0 references

page(s)

e11542

0 references

copyright license

4 references

23 March 2019

21 March 2019

1 July 2020

on focus list of Wikimedia project

25 October 2022

copyright status

copyrighted

0 references

ScienceSource

0 references

cites work

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903479

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903479

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903479

Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903479

Diagnosis, management, and treatment of hepatitis C: an update

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903479

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903479

Ophthalmologic complications in children with chronic hepatitis C treated with pegylated interferon

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903479

Chronic hepatitis C virus infection in children.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903479

Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903479

Pathology of chronic hepatitis C in children: liver biopsy findings in the Peds-C Trial.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903479

Hepatitis C in children and adolescents: mode of acquisition, natural history and treatment.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903479

An analysis of published trials of interferon monotherapy in children with chronic hepatitis C.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903479

Studies of the effectiveness of interferon alpha treatment for chronic hepatitis C in children.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903479

Favorable response to lymphoblastoid interferon-alpha in children with chronic hepatitis C

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903479

Prevalence of anti-hepatitis C virus antibodies among teenagers in the Venetian area: a seroepidemiological study

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903479

Human leukocyte alpha interferon-induced transient neurotoxicity in children

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903479

Seroprevalence of anti-HCV in an urban child population: a pilot survey in a developing area, Cameroon

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903479

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection in children and adolescents

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903479

Efficacy and safety of peginterferon-alpha2b and ribavirin combination therapy in children with chronic hepatitis C infection

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903479

Recombinant alfa-interferon plus ribavirin therapy in children and adolescents with chronic hepatitis C.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903479

Peginterferon alfa-2b plus ribavirin treatment in children and adolescents with chronic hepatitis C.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903479

Interferon-alpha-2b treatment of chronic hepatitis C in children with hemophilia

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903479

Clinical and virologic features of hepatitis C virus infection associated with intravenous immunoglobulin.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903479

Prevalence of antibody to hepatitis C virus in Japanese schoolchildren: comparison with adult blood donors

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903479

Treatment of children with chronic hepatitis C with recombinant interferon-alpha: a pilot study

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903479

Persistence rate and progression of vertically acquired hepatitis C infection. European Paediatric Hepatitis C Virus Infection

30 May 2018

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0011542

Chronic hepatitis C virus infection in childhood: clinical patterns and evolution in 224 white children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0011542

Chronic hepatitis C in childhood: an 18-year experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0011542

The natural history of hepatitis C virus in pediatric liver transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0011542

Is alpha-interferon treatment useful in children with non-B, non-C chronic hepatitis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0011542

Hepatitis C in adults and adolescents with hemophilia: a randomized, controlled trial of interferon alfa-2b and ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0011542

Does interferon and ribavirin combination therapy increase the rate of treatment response in children with hepatitis C?

21 January 2018

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0011542

Safety, efficacy and pharmacokinetics of peginterferon alpha2a (40 kd) in children with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0011542

Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0011542

Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0011542

Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0011542

Interferon-alpha treatment of chronic hepatitis C virus infection in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0011542

Interferon-alpha treatment of chronic hepatitis C in children with hemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0011542

Efficacy of interferons in treating children with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0011542

Virus genotype 1b and long-term response to interferon alpha monotherapy in children with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0011542

Efficacy of interferon-alpha treatment in Japanese children with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0011542

Low virological response to interferon in children with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0011542

Response to interferon alfa-2b therapy in mutitransfused children with beta-thalassemia and chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0011542

Interferon-alpha and ribavirin treatment of hepatitis C in children with malignancy in remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0011542

Interferon alpha and ribavirin in the treatment of children with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0011542

Interferon alfa-2b in combination with ribavirin for the treatment of chronic hepatitis C in children: efficacy, safety, and pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0011542

Combination therapy with ribavirin and interferon in a cohort of children with hepatitis C and haemophilia followed at a pediatric haemophilia treatment center

21 January 2018

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0011542

Response to pegylated interferon alpha-2b and ribavirin in children with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0011542

Fibrosis in chronic hepatitis C acquired in infancy: is it only a matter of time?

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903479

Interferon alpha for eradication of HCV and remission of chronic hepatitis in children.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903479

Efficacy of interferon in treating chronic hepatitis C in children with a history of acute leukemia

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903479

Recombinant interferon-alfa therapy in children with chronic hepatitis C.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903479

Response to interferon therapy in children with chronic hepatitis C

29 November 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/20644626

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Effect of iron overload on the response to recombinant interferon-alfa treatment in transfusion-dependent patients with thalassemia major and chronic hepatitis C

1 reference

https://pubmed.ncbi.nlm.nih.gov/20644626

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1371/JOURNAL.PONE.0011542

0 references

0 references

0 references